Since November 2005, all new cancer agents have to be approved centrally for the EU by the EMA, and there has been a growing interest from various players national medicines agencies, the pharmaceutical industry and patient groups in its decision-making processes and how they compare with what many consider to be the gold standard approval body, the Food and Drug Administration (FDA) in the US
In contrast, branded and generic medicines are rigorously tested to gain FDA approval and facilities that manufacture FDA-approved products are inspected before they start production as well as other times during the approval process
Two 2013 systematic reviews of interventions concluded that the modest benefit of propionyl-L-carnitine on walking performance was equivalent or superior to that obtained with drugs approved for claudication in the US (e.g., pentoxyphylline, cilostazol) yet inferior to improvements seen with supervised exercise interventions (69, 70)
self-pay market with a new pricing initiative offering the first two doses of Wegovy and Ozempic for $199 a month a dramatic markdown designed to widen affordability while fending off rising competition in the GLP-1 category
Compared to previous studies, the findings presented in this report offer a more nuanced understanding of non-linear weight changes over 12 months, stratified by key patient characteristics
Schulz, J